Evidence and strategies for the primary prevention of type 2 diabetess

Diabetes and Primary Care

Volumn 11, Issue 3, 2009, Pages 182-186

  Kazmi, Syeda ^a   Taylor, Hina ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cost implications; Impaired glucose tolerance; Lifestyle changes; Prevention; Screening; Type 2 diabetes

Indexed keywords

EID: 68149159234     PISSN: 14668955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Pediatrics 105 (3 Pt 1): 671-80
2. American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27 (Suppl 1): 11-14
3. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases (2002) The prevention or delay of type 2 diabetes. Diabetes Care 25: 742-9
4. Arslanian S (2002) Type 2 diabetes in children: clinical aspects and risk factors. Horm Res 57 (Suppl 1): 19-28
5. Caro JJ, Getsios D, Caro I et al (2004) Economic evaluation of therapeutic interventions to prevent type 2 diabetes in Canada. Diabet Med 21: 1229-36
6. Chiasson JL (2006) Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract 12 (Suppl 1): 25-30
7. Chowdhury TA, Grace C, Kopelman PG (2003) Preventing diabetes in South Asians. BMJ 324:1059-60
8. Department of Health Social Services and Public Safety (2008) Quality & Outcomes Framework (QOF) April 2007 - March 2008, Northern Ireland nGMS practices. Available at: http://tiny.cc/Vw7Yh (accessed 16.01.09)
9. Diabetes UK (2006) Early identification of people with type 2 diabetes. Diabetes UK, London. Available at: http://tiny.cc/kHPRx (accessed 19.01.09)
10. DREAM Trial Investigators; Gerstein HC, Yusuf S, Bosch J et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096-105
11. Eddy DM, Schlessinger L, Kahn R (2005) Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 143: 251-64
12. Eriksson KF, Lindgärde F (1991) Prevention of type 2 (noninsulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmö feasibility study. Diabetologia 34: 891-8
13. Herman WH, Hoerger TJ, Brandle M et al; Diabetes Prevention Program Research Group (2005) The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142:323-32
14. Holman RR, Blackwell L, Stratton IM et al (2003) Six-year results from the Early Diabetes Intervention Trial. Diabet Med 20 (Suppl 2): 15
15. Information Services Division Scotland (2008) Quality and Outcomes Framework (QOF) fir April 2007 - March 2008, Scotland. ISD, Edinburgh. Available at: http://tiny.cc/OCDGl (accessed 16.01.09)
16. International Diabetes Federation (2008) Health Economics of Diabetes Prevention. IDF, Brussels. Available at: http://tiny.cc/8M9wn (accessed 19.01.09)
17. Knowler WC, Barrett-Connor E, Fowler SE et al; Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl JMed 346:393-403
18. Lawrence JM, Bennett P, Young A, Robinson AM (2001) Screening for diabetes in general practice: cross sectional population study. BMJ 323: 548-51
19. Lowe LP, Liu K, Greenland P et al (1997) Diabetes, asymptomatic hyperglycaemia and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care 20: 163-9
20. Mantavani L, Palmer AJ, Morgutti M et al (2004) Long-term cost-effectiveness of the Diabetes Prevention Program in an Italian setting. 40th Annual Meeting of the European Association fir the Study of Diabetes, 5-9 September, Munich, Germany (A955)
21. Palmer AJ, Roze S, Valentine WJ et al (2004a) Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 26:304-21
22. Palmer AJ, Roze S, Valentine WJ, Renaudin C (2004b) Costeffectiveness analysis of the Diabetes Prevention Program in a Spanish setting. Value Health 7:74\ (PDB22)
23. Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-44
24. Pan CY, Gao Y, Chen JW et al (2003) Efficacy of acarbose in Chinese subjects with impaired glucose tolerance. Diabetes Res ClinPract 61: 183-90
25. Quilici S, Chancellor J, Maclaine G et al (2005) Costeffectiveness of acarbose for the management of impaired glucose tolerance in Sweden. Int J Clin Pract 59:1143-52
26. Scheen AJ (2003) Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Drugs 63:933-51
27. Simpson RW, Shaw JE, Zimmet PZ (2003) The prevention of type 2 diabetes: lifestyle changes or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract 59: 165-80
28. The Information Centre (2008) Quality and Outcomes Framework (QOF) fir April 2007 to March 2008, England. The Information Centre, Leeds. Available at: http://tiny.cc/qBOkZ (accessed 16.01.09)
29. Torgerson JS, Hauptman J, Boldrim MN, Sjöström L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Carc 27:155-61
30. Tuomilehto J, Lindström J, Eriksson JG et al; Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-50
31. Welsh Assembly Government, HSAI (2008) Hlth1108: Patients Recorded on QOF Disease Registers. Available at: http://tiny.cc/v6sRl (accessed 16.01.09)